Brain Pulsations Linked to High BMI
Brain Pulsations Linked to High BMI

According to a new study from the University of Oulu in Finland, alterations in the.

Brain Age Estimation: EEG Advancements in Neurology
Brain Age Estimation: EEG Advancements in Neurology

To estimate brain age using EEG scans, researchers devised an AI-based approach that may help.

Retinal Neurodegeneration in Parkinson's Disease Study
Retinal Neurodegeneration in Parkinson’s Disease

By measuring the thickness of the retina, optical coherence tomography—a technique frequently used in eye.

Role of Engineered Peptides in Cancer Immunotherapy
Role of Engineered Peptides in Cancer Immunotherapy

In a recent publication in Nature Biomedical Engineering, scientists at The University of Texas MD.

Neoadjuvant Chemotherapy in Ovarian Cancer During COVID-19 Pandemic
Neoadjuvant Chemotherapy Boosts Ovarian Cancer

During the COVID-19 pandemic, US women with ovarian cancer (OC) used more neoadjuvant chemotherapy to.

Image showing a person taking a vitamin D supplement to address deficiency
Nutrient Optimization: Vitamin D for Health

Researchers addressed the prevalence of vitamin D deficiency despite its broad availability through food, pills,.

Atopic Dermatitis (AD) Linked to Increased Risk of Headache Disorders: Study Reveals
AD and Headache Disorders: Recent Findings

Atopic dermatitis (AD) patients may be more susceptible to migraines and headache disorders. A study.

Illustration of two medical vials labeled "Eculizumab" and "Ravulizumab," representing treatments for myasthenia gravis.
Myasthenia Gravis Treatment: Eculizumab & Ravulizumab

A recent study found that myasthenia gravis treatment with eculizumab (Soliris; Alexion) is a useful.

FDA approves benralizumab (Fasenra) for children with severe eosinophilic asthma, improving treatment options and patient outcomes.
Eosinophilic Asthma Treatment: FDA Approves Benralizumab

According to a news release from AstraZeneca, the FDA has approved benralizumab (Fasenra) for children.

Insights into DCB-Only Strategy for Left Main Coronary Artery Disease
Insights into DCB-Only Strategy for Left Main Coronary Artery Disease

Sanna Uskela and colleagues, from the Heart Center at North Karelia Central Hospital in Finland,.